Target Price | $450.68 |
Price | $308.01 |
Potential | 46.32% |
Number of Estimates | 22 |
22 Analysts have issued a price target UnitedHealth 2026 . The average UnitedHealth target price is $450.68. This is 46.32% higher than the current stock price. The highest price target is $594.00 92.85% , the lowest is $350.00 13.63% . | |
A rating was issued by 29 analysts: 23 Analysts recommend UnitedHealth to buy, 5 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the UnitedHealth stock has an average upside potential 2026 of 46.32% . Most analysts recommend the UnitedHealth stock at Purchase. |
21 Analysts have issued a sales forecast UnitedHealth 2025 . The average UnitedHealth sales estimate is $450b . This is 9.85% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $458b 11.76% , the lowest is $444b 8.24% .
This results in the following potential growth metrics:
2024 | $400b | 8.83% |
---|---|---|
2025 | $450b | 12.53% |
2026 | $481b | 6.79% |
2027 | $513b | 6.60% |
2028 | $552b | 7.74% |
2029 | $613b | 10.90% |
15 UnitedHealth Analysts have issued a net profit forecast 2025. The average UnitedHealth net profit estimate is $21.0b . This is 3.50% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $22.6b 3.89% , the lowest is $18.8b 13.67% .
This results in the following potential growth metrics and future Net Margins:
2024 | $14.1b | 35.00% |
---|---|---|
2025 | $21.0b | 48.83% |
2026 | $24.2b | 15.27% |
2027 | $28.1b | 16.11% |
2028 | $33.2b | 17.98% |
2029 | $37.7b | 13.75% |
2024 | 3.53% | 40.27% |
---|---|---|
2025 | 4.66% | 32.16% |
2026 | 5.03% | 7.94% |
2027 | 5.48% | 8.95% |
2028 | 6.00% | 9.49% |
2029 | 6.16% | 2.67% |
15 Analysts have issued a UnitedHealth forecast for earnings per share. The average UnitedHealth EPS is $23.08 . This is 3.51% lower than earnings per share in the financial year 2024. The highest EPS forecast is $24.85 3.89% , the lowest is $20.65 13.67% .
This results in the following potential growth metrics and future valuations:
2024 | $15.51 | 35.00% |
---|---|---|
2025 | $23.08 | 48.81% |
2026 | $26.61 | 15.29% |
2027 | $30.89 | 16.08% |
2028 | $36.45 | 18.00% |
2029 | $41.46 | 13.74% |
Current | 12.88 | 58.89% |
---|---|---|
2025 | 13.34 | 3.57% |
2026 | 11.58 | 13.19% |
2027 | 9.97 | 13.90% |
2028 | 8.45 | 15.25% |
2029 | 7.43 | 12.07% |
Based on analysts' sales estimates for 2025, the UnitedHealth stock is valued at an EV/Sales of 0.76 and an P/S ratio of 0.62 .
This results in the following potential growth metrics and future valuations:
Current | 0.83 | 40.29% |
---|---|---|
2025 | 0.76 | 9.04% |
2026 | 0.71 | 6.36% |
2027 | 0.66 | 6.20% |
2028 | 0.62 | 7.18% |
2029 | 0.56 | 9.83% |
Current | 0.68 | 45.19% |
---|---|---|
2025 | 0.62 | 8.97% |
2026 | 0.58 | 6.35% |
2027 | 0.54 | 6.20% |
2028 | 0.51 | 7.19% |
2029 | 0.46 | 9.83% |
Analyst | Rating | Action | Date |
---|---|---|---|
Oppenheimer |
Outperform
➜
Outperform
|
Unchanged | May 14 2025 |
Keybanc |
Overweight
➜
Overweight
|
Unchanged | May 14 2025 |
B of A Securities |
Buy
➜
Neutral
|
Downgrade | May 14 2025 |
Baird |
Outperform
➜
Outperform
|
Unchanged | May 14 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | May 14 2025 |
Deutsche Bank |
Buy
➜
Buy
|
Unchanged | May 14 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | May 14 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Oppenheimer:
Outperform
➜
Outperform
|
May 14 2025 |
Unchanged
Keybanc:
Overweight
➜
Overweight
|
May 14 2025 |
Downgrade
B of A Securities:
Buy
➜
Neutral
|
May 14 2025 |
Unchanged
Baird:
Outperform
➜
Outperform
|
May 14 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
May 14 2025 |
Unchanged
Deutsche Bank:
Buy
➜
Buy
|
May 14 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
May 14 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.